VACBF 股價走勢圖
VACBF 收益
Nykode Therapeutics AS
$0
0%
$0
收盤價：Jun 23, 16:00:00 GMT-4
$0
0%
$0
盤後：Jun 23, 20:00:00 GMT-4
返回
Nykode Therapeutics AS (VACBF) 收益
關鍵數據
前收市價
$0.3247
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
--
股息收益率
--
每股盈餘 (TTM)
--
市值
--
什麼是 NYKODE THERAPEUTICS ASA？
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company employs 59 full-time employees The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
